John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$166M |
| 2 |
General Motors
GM
|
+$156M |
| 3 |
Union Pacific
UNP
|
+$154M |
| 4 |
Pfizer
PFE
|
+$124M |
| 5 |
McDonald's
MCD
|
+$124M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$132M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$124M |
| 3 |
Liberty Global Class A
LBTYA
|
+$120M |
| 4 |
Freeport-McMoran
FCX
|
+$110M |
| 5 |
Vodafone
VOD
|
+$80.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.69% |
| 2 | Healthcare | 12.24% |
| 3 | Technology | 11.21% |
| 4 | Energy | 10.78% |
| 5 | Financials | 10.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BERY
426
DELISTED
Berry Global Group, Inc.
BERY
| $7.1M | 0.05% |
386,981
-38,557
| -9% | -$803K |
|
427
SEI Investments
SEIC
$13.1B
| $7.07M | 0.05% |
228,642
-111,501
| -33% | -$3.44M |
|
|
QCOR
428
DELISTED
QUESTCOR PHARMA INC
QCOR
| $7.05M | 0.04% |
121,514
+79,535
| +189% | +$4.73M |
|
429
Bio-Rad Laboratories Class A
BIO
$10.2B
| $7.01M | 0.04% |
59,601
-13,309
| -18% | -$1.57M |
|
430
Hyatt Hotels
H
$17B
| $7M | 0.04% |
162,843
+107,753
| +196% | +$4.73M |
|
431
Cognizant
CTSH
$27.9B
| $6.96M | 0.04% |
169,454
-1,581,264
| -90% | -$58.7M |
|
|
HME
432
DELISTED
HOME PROPERTIES, INC
HME
| $6.96M | 0.04% |
120,456
-61,630
| -34% | -$3.78M |
|
|
HTSI
433
DELISTED
HARRIS TEETER SUPERMARKETS INC COM STK (NC)
HTSI
| $6.91M | 0.04% |
140,546
+135,737
| +2,823% | +$6.67M |
|
|
HSH
434
DELISTED
HILLSHIRE BRANDS CO
HSH
| $6.91M | 0.04% |
224,808
-731,031
| -76% | -$24.2M |
|
|
HMA
435
DELISTED
HEALTH MGMT ASSOC INC CL-A
HMA
| $6.89M | 0.04% |
+538,586
| New | +$7.48M |
|
|
GG
436
DELISTED
Goldcorp Inc
GG
| $6.87M | 0.04% |
264,173
+166,126
| +169% | +$4.58M |
|
437
Graham Holdings Company
GHC
$4.94B
| $6.86M | 0.04% |
18,572
+9,839
| +113% | +$3.31M |
|
438
Public Storage
PSA
$60.2B
| $6.83M | 0.04% |
42,516
-222,477
| -84% | -$35.2M |
|
439
Oil States International
OIS
$522M
| $6.8M | 0.04% |
115,103
-547,199
| -83% | -$29.9M |
|
440
Charles River Laboratories
CRL
$14.1B
| $6.78M | 0.04% |
146,520
-13,739
| -9% | -$630K |
|
441
Norfolk Southern
NSC
$78.8B
| $6.76M | 0.04% |
87,360
-287,467
| -77% | -$21.5M |
|
442
Itaú Unibanco
ITUB
$82.4B
| $6.74M | 0.04% |
1,310,511
-5,299,682
| -80% | -$24.8M |
|
443
Bristol-Myers Squibb
BMY
$137B
| $6.74M | 0.04% |
+145,518
| New | +$6.39M |
|
444
Fortinet
FTNT
$113B
| $6.73M | 0.04% |
1,661,110
-794,705
| -32% | -$3.22M |
|
445
Hancock Whitney
HWC
$6.05B
| $6.73M | 0.04% |
214,433
+63,036
| +42% | +$2.04M |
|
446
UnitedHealth
UNH
$350B
| $6.64M | 0.04% |
92,684
-67,908
| -42% | -$4.86M |
|
447
LPL Financial
LPLA
$28.5B
| $6.61M | 0.04% |
172,525
-1,314
| -0.8% | -$50.3K |
|
|
PDCO
448
DELISTED
Patterson Companies, Inc.
PDCO
| $6.61M | 0.04% |
164,298
-1,494
| -0.9% | -$60.5K |
|
|
AAWW
449
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $6.58M | 0.04% |
142,661
+21,896
| +18% | +$990K |
|
|
RKT
450
DELISTED
ROCK-TENN COMPANY CL-A
RKT
| $6.56M | 0.04% |
129,558
-139,384
| -52% | -$7.79M |
|
Similar funds
John Overdeck's Q3 2013 Portfolio in Review
As of Q3 2013, John Overdeck held 2,423 positions worth $15.7B, up 9.6% from $14.3B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.
John Overdeck deployed $511M of net new capital in Q3 2013, opening 482 new positions and adding to 549 existing holdings. Its largest new stake was Johnson & Johnson: 1,855,436 shares worth $161M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 12% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was EMC CORPORATION, an estimated $124M trimmed.
- John Overdeck's largest Q3 2013 buy was Johnson & Johnson: 1,855,436 shares worth $161M.
- John Overdeck added most to Alphabet (Google) Class C in Q3 2013, an estimated $100M increase.
- John Overdeck's biggest Q3 2013 reduction was EMC CORPORATION, cutting an estimated $124M.
- John Overdeck fully exited IBM in Q3 2013, selling an estimated $132M.
- John Overdeck's ten largest holdings make up 9.4% of its $15.7B portfolio in Q3 2013.
- John Overdeck opened 482 new positions and closed 621 in Q3 2013.
- John Overdeck's portfolio value rose 9.6% quarter-over-quarter to $15.7B.
Based on Two Sigma Investments's 13F filing for Q3 2013, filed 14 Nov 2013.